🔗 Permalink

Assignee profile:

LigoCyte Pharmaceuticals, Inc.

City:

Bozeman, Montana

Country:

United States

Published Applications:

Last publication date:

2013-02-28

Patent Grants:

Last grant date:

2015-03-17

Top Inventors for applications by LigoCyte Pharmaceuticals, Inc.

These are the the leading inventors for applications assigned to LigoCyte Pharmaceuticals, Inc.:

Joel R. Haynes 4 Bozeman, MT United States
Charles RICHARDSON 3 Bozeman, MT United States
Bryan Steadman 3 Bozeman, MT United States
Thomas R. FOUBERT 2 Bozeman, MT United States

William T. Tino 1 Belgrade, MT United States
THOMAS S. VEDVICK 1 BOZEMAN, MT United States
Susan Wimer-Mackin 1 Bozeman, MT United States
Robert F. BARGATZE 1 Bozeman, MT United States

Ross Taylor 1 Bozeman, MT United States
Thomas S. VEDVICK 1 Federal Way, WA United States
Joel HAYNES 1 Bozeman, MT United States

Recent patent applications by LigoCyte Pharmaceuticals, Inc.

LigoCyte Pharmaceuticals, Inc. based in Bozeman, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2013-02-28 ✅ Patent 8,980,275 granted on 2015-03-17

US20130052216A1

Chemistry; metallurgy

Targeted heterologous antigen presentation on calicivirus virus-like particles

#2 | 2013-01-31

US20130028933A1

Human necessities

METHODS FOR STABILIZING INFLUENZA ANTIGEN ENVELOPED VIRUS-BASED VIRUS-LIKE PARTICLE SOLUTIONS

#3 | 2012-04-19

US20120093855A1

Chemistry; metallurgy

RSV F VLPs AND METHODS OF MANUFACTURE AND USE THEREOF

#4 | 2011-08-11 ✅ Patent 8,841,120 granted on 2014-09-23

US20110195113A1

Chemistry; metallurgy

Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity

#5 | 2010-10-21

US20100266636A1

Human necessities

METHOD OF CONFERRING A PROTECTIVE IMMUNE RESPONSE TO NOROVIRUS

#6 | 2010-03-25 ✅ Patent 9,439,959 granted on 2016-09-13

US20100074915A1

Human necessities

Chimeric influenza virus-like particles

#7 | 2010-02-25

US20100047266A1

Chemistry; metallurgy

CHIMERIC VIRUS-LIKE PARTICLES

#8 | 2008-12-04 ✅ Patent 7,955,603 granted on 2011-06-07

US20080299152A1

Human necessities

Norovirus vaccine formulations

#9 | 2007-08-30 ✅ Patent 8,409,590 granted on 2013-04-02

US20070202130A1

Human necessities

Anthrax antigens and methods of use

AssigneeID:

7108 ⎘